Skip to main content
BLSM filings

Corporate insider profile

Jason A Keyes Filing Activity

Latest reported as Chief Financial Officer of BlossomHill Therapeutics, Inc. (BLSM).

Purchase filings
1
Reported companies
1
Net open-market value
$11,200
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026BlossomHill Therapeutics, Inc. (BLSM)Chief Financial OfficerOpen Market Purchase700$16.00$11,200